Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 9.80% is 16% below its 5-year average of 11.69%, around the middle of its 5-year range (1.54%–26.12%).
As of the fiscal period ended Tuesday, June 30, 2026. 21.63% above its 12-month average of 8.06%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 9.80%.
DEBT TO ASSETS RATIO
9.80%
DEBT TO ASSETS RATIO AVG TTM
8.06%
DEBT TO ASSETS RATIO AVG 3Y
5.96%
DEBT TO ASSETS RATIO AVG 5Y
11.69%
DEBT TO ASSETS RATIO AVG 10Y
14.33%
DEBT TO ASSETS RATIO AVG 15Y
8.28%
DEBT TO ASSETS RATIO AVG 20Y
6.52%
CURRENT VS TTM AVG
+21.63%
CURRENT VS 3Y AVG
+64.50%
CURRENT VS 5Y AVG
-16.12%
CURRENT VS 10Y AVG
-31.62%
CURRENT VS 15Y AVG
+18.38%
CURRENT VS 20Y AVG
+50.36%
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 597 covered companies
CURRENT VS SECTOR MEDIAN
+9701.88%
vs the sector median at left
EyePoint Pharmaceuticals, Inc.
Market Cap
$259.49M
Debt to Assets Ratio
9.80%
TTM Avg
8.06%
3Y Avg
5.96%
5Y Avg
11.69%
Market Cap
$261.43M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$255.95M
Debt to Assets Ratio
0.13%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$264.16M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$255.42M
Debt to Assets Ratio
0.12%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$250.09M
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$272.17M
Debt to Assets Ratio
0.29%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| EyePoint Pharmaceuticals, Inc. (EYPT) | $259.49M | 9.80% | 8.06% | 5.96% | 11.69% |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $261.43M | 0.00% | N/A | N/A | N/A |
| AC Immune S.A. (ACIU)vs › | $256.98M | 0.03% | N/A | N/A | N/A |
| Anika Therapeutics, Inc. (ANIK)vs › | $255.95M | 0.13% | N/A | N/A | N/A |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $264.16M | 0.01% | N/A | N/A | N/A |
| Century Therapeutics, Inc. (IPSC)vs › | $255.42M | 0.12% | N/A | N/A | N/A |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $250.09M | 0.03% | N/A | N/A | N/A |
| Fate Therapeutics, Inc. (FATE)vs › | $272.17M | 0.29% | N/A | N/A | N/A |
| Invivyd, Inc. (IVVD)vs › | $246.20M | 0.04% | N/A | N/A | N/A |
| Indaptus Therapeutics, Inc. (INDP)vs › | $274.61M | 0.00% | N/A | N/A | N/A |
Debt/Assets
9.8%
Debt/Equity
0.13
Current Ratio
4.50
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 9.80% |
| 2026-03-31 | 7.74% |
| 2025-12-31 | 6.26% |
| 2025-09-30 | 9.24% |
| 2025-06-30 | 7.24% |
| 2025-03-31 | 6.64% |
| 2024-12-31 | 5.22% |
| 2024-09-30 | 7.29% |
| 2024-06-30 | 7.18% |
| 2024-03-31 | 1.74% |
| 2023-12-31 | 1.54% |
| 2023-09-30 | 3.90% |
| 2023-06-30 | 3.66% |
| 2023-03-31 | 26.12% |
| 2022-12-31 | 25.70% |
| 2022-09-30 | 21.07% |
| 2022-06-30 | 19.06% |
| 2022-03-31 | 16.88% |
| 2021-12-31 | 14.89% |
| 2021-09-30 | 22.83% |
| 2021-06-30 | 21.39% |
| 2021-03-31 | 21.53% |
| 2020-12-31 | 44.70% |
| 2020-09-30 | 69.35% |
| 2020-06-30 | 75.89% |
| 2020-03-31 | 62.87% |
| 2019-12-31 | 69.35% |
| 2019-09-30 | 63.52% |
| 2019-06-30 | 54.57% |
| 2019-03-31 | 43.53% |
| 2018-12-31 | 22.54% |
| 2018-09-30 | 19.65% |
| 2018-06-30 | 24.15% |
| 2018-03-31 | 25.62% |
| 2017-12-31 | 121.92% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | 0.00% |
| 2006-12-31 | 9.29% |
| 2006-06-30 | 6.44% |
| 2005-06-30 | 0.00% |
| 2004-06-30 | 0.00% |
| 2003-06-30 | 0.00% |
